3313 articles
Kimberly Smith, Head of Research and Development at ViiV Healthcare discusses recent advancements made in HIV studies and the impact COVID-19 has had on...
Barbara White, Chief Medical Officer and Head of Research at Corbus Pharmaceuticals discusses Lenabasum, Corbus’ lead drug candidate that activates th...
Paul Wotton, CEO of Obsidian Therapeutics, discusses Obsidian’s platform, cytoDRiVE™, that regulates protein levels in cell and gene therapies, crea...
Phillip Gomez, Ph.D., CEO at SIGA Technologies, Inc., discusses how the field of Health Security has transformed after the anthrax attacks in the United...
Ken Perez, VP of Healthcare Policy for Omnicell discusses the launch of Omnicell One, the first tech-enabled service for health system pharmacies that l...
Chris Bradley, CEO of Loki Therapeutics discusses Loki's proprietary AWAKE™ strategy that completely bypasses the major challenges faced by traditiona...
Gwen Nichols, Chief Medical Officer at the Leukemia & Lymphoma Society (LLS) discusses the Children's Initiative, a $100M dollar effort to address the l...
Clinician safety is the top priority during the COVID-19 crisis. Learn more on Health Professional Radio.
Recent research suggests that the loss of muscle mass is associated with compromised immunity and infections. Dr. Learn more on Health Professional Radio.
Avi Fischer, M.D., Divisional Vice President, MedicalAffairs, and Chief Medical Officer for Cardiac RhythmManagement (CRM) at Abbott discusses the recen...